NovaBay Pharmaceuticals (NBY) News Today $1.20 -0.06 (-4.76%) Closing price 10/8/2025 04:10 PM EasternExtended Trading$1.18 -0.02 (-1.67%) As of 07:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock NBY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period NovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder ValueSeptember 25, 2025 | finance.yahoo.comNovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder ValueSeptember 23, 2025 | insidermonkey.comNovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual MeetingSeptember 18, 2025 | globenewswire.comNovaBay Pharma Announces Special Cash DividendAugust 26, 2025 | msn.comNovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per ShareAugust 26, 2025 | finance.yahoo.comWhy Is NovaBay Pharmaceuticals Stock (NBY) Up 60% Today?August 20, 2025 | msn.comNovaBay Pharma Appoints New CEO Amid Strategic ShiftAugust 20, 2025 | msn.comNovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. LazarAugust 19, 2025 | globenewswire.comNBY NovaBay Pharmaceuticals, Inc. - Seeking AlphaJune 29, 2025 | seekingalpha.comNovaBay Pharmaceuticals, Inc. (NBY) - Yahoo FinanceJune 26, 2025 | finance.yahoo.comNovaBay Pharmaceuticals Inc. Stock Grades | NBY | Barron'sMay 26, 2025 | barrons.comNovaBay Pharmaceuticals approves liquidation planApril 24, 2025 | uk.investing.comNovaBay Pharmaceuticals, Inc. (NYSE:NBY) Major Shareholder Poplar Point Capital Partners Acquires 21,654 SharesApril 16, 2025 | insidertrades.comNovaBay Pharmaceuticals Delays Yearly Report FilingApril 1, 2025 | tipranks.comNovaBay Pharmaceuticals to Hold Special Meeting of StockholdersMarch 7, 2025 | businesswire.comNovaBay fails to gain shareholder approval for dissolutionFebruary 5, 2025 | msn.comNovaBay Pharmaceuticals Inc NBYFebruary 1, 2025 | morningstar.comMNovaBay extends CEO's contract through 2025January 22, 2025 | msn.comNovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of StockholdersDecember 19, 2024 | businesswire.comNovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special MeetingDecember 9, 2024 | businesswire.comNovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024November 22, 2024 | businesswire.comNovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase PriceNovember 6, 2024 | businesswire.comNovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLCOctober 29, 2024 | finance.yahoo.comNovaBay Pharmaceuticals receives unsolicited offer from Refresh AcquisitionsOctober 29, 2024 | msn.comNovaBay Pharmaceuticals (AMEX:NBY) Stock, Short Interest ReportSeptember 26, 2024 | benzinga.comNovaBay Pharmaceuticals (AMEX:NBY) Stock Quotes, Forecast and News SummarySeptember 26, 2024 | benzinga.comNovaBay Pharmaceuticals To Sell Assets Of Its Avenova Brand - Quick FactsSeptember 21, 2024 | markets.businessinsider.comWhat's Going On With NovaBay Pharmaceuticals Shares Friday?September 20, 2024 | msn.comNBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.'s Avenova Brand and Business Is Fair to ShareholdersSeptember 20, 2024 | businesswire.comAcumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay PharmaceuticalsSeptember 20, 2024 | finance.yahoo.comAcumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay PharmaceuticalsSeptember 20, 2024 | prnewswire.comNovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova AssetsSeptember 20, 2024 | businesswire.comNOVABAY PHARMAC. DL-,01 (B9P0.MU)September 14, 2024 | sg.finance.yahoo.comNovaBay Pharmaceuticals, Inc. (B9P0.F)August 20, 2024 | finance.yahoo.comNovaBay Pharmaceuticals, Inc. (NBY) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | seekingalpha.comNovaBay Pharmaceuticals Reports Second Quarter 2024 Financial ResultsAugust 13, 2024 | finance.yahoo.comNovaBay Pharmaceuticals Inc. Q2 Loss DropsAugust 13, 2024 | markets.businessinsider.comNovaBay Q2 2024 Earnings PreviewAugust 12, 2024 | msn.comNovaBay reports surge in Avenova sales during Prime DayAugust 1, 2024 | uk.investing.comNovaBay Pharmaceuticals Reports Record Amazon Prime Day SalesJuly 30, 2024 | finance.yahoo.comWhat's Going On With NovaBay Pharmaceuticals (NBY) Stock?July 29, 2024 | msn.comNovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment OptionJuly 29, 2024 | finance.yahoo.comDow Surges 550 Points; Headline PCE Price Index Falls To 2.5%July 26, 2024 | msn.comNovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public OfferingJuly 26, 2024 | finance.yahoo.comWhy NovaBay Pharmaceuticals (NBY) Stock Is Down 60%July 26, 2024 | benzinga.comNovabay Pharmaceuticals IncJuly 25, 2024 | money.usnews.comNovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product PromotionsJune 28, 2024 | businesswire.comNovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE AmericanJune 7, 2024 | businesswire.comWhy Is NovaBay Pharmaceuticals (NBY) Stock Down 39% Today?May 30, 2024 | investorplace.comNovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate UpdatesMay 29, 2024 | businesswire.com Get NovaBay Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NBY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NBY Media Mentions By Week NBY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBY News Sentiment▼0.000.63▲Average Medical News Sentiment NBY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBY Articles This Week▼00▲NBY Articles Average Week Get the Latest News and Ratings for NBY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for NovaBay Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AKTX News ADAP News ITRM News PYRGF News OTLC News ALVR News DARE News KZR News CVKD News KLTO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:NBY) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovaBay Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
